SoftSol India Seeks Shareholder Approval for Aravind Kumar Madala's Appointment as Managing Director

Softsol Limited, a real estate and property leasing company, has announced a significant change in its leadership structure. The company is seeking shareholder approval for the appointment of Dr. Aravind Kumar Madala as a Director and Managing Director through a postal ballot notice.

Key Appointments and Resolutions

SoftSol India has proposed two resolutions for shareholder approval:

Appointment of Dr. Aravind Kumar Madala as a Director of the company.
Appointment of Dr. Madala as the Managing Director for a five-year term from September 1, 2025, to August 31, 2030.

About Dr. Aravind Kumar Madala

Dr. Madala brings a unique blend of medical expertise and management experience to SoftSol India:

General Physician with over 19 years of experience
Completed medical education at Kasturba Medical College, Mangalore (1996-2006)
Experience in healthcare administration
Strong background in leadership and management

Proposed Remuneration and Terms

The company has outlined the following terms for Dr. Madala's appointment:

Aspect	Details
Tenure	5 years (September 1, 2025 to August 31, 2030)
Remuneration Period	3 years (September 1, 2025 to August 31, 2028)
Fixed Salary	Rs. 2,00,000 per month
Additional Benefits	Provident Fund, Superannuation Fund, Gratuity, Leave Encashment

Voting Process

SoftSol India has initiated an e-voting process for these resolutions:

E-voting period: October 17, 2025 (9:00 AM IST) to November 15, 2025 (5:00 PM IST)
Results to be declared within 48 hours of the conclusion of e-voting

Company Background

SoftSol India Limited, with its registered office in Hyderabad, is primarily engaged in real estate-related activities, including leasing of properties or spaces. The company reported a total revenue of Rs. 1866.85 lakhs and a net profit of Rs. 863.56 lakhs for the financial year 2024-2025.

This strategic move by SoftSol India to bring Dr. Madala on board as Managing Director could potentially bring a fresh perspective to the company's operations, given his diverse background in healthcare and administration. Shareholders will play a crucial role in determining the company's future direction through their votes on these significant appointments.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.14%	+5.47%	+3.07%	+12.01%	-40.04%	+509.20%

Softsol India Limited has announced a significant increase in its quarterly profit and the appointment of a new Managing Director, signaling a period of growth and transition for the company.

Financial Performance

For the quarter ended June 30, Softsol India reported a robust financial performance:

Metric	Q1 FY2026	Q1 FY2025	YoY Change
Profit	₹443.96	₹256.55	73.00%
Total Income	₹620.63	₹502.10	23.60%
Revenue from Operations	₹338.83	₹320.28	5.80%
Basic EPS	₹3.01	₹1.74	73.00%

The company's profit for the quarter saw a substantial increase of 73% year-over-year, rising to ₹443.96 crore from ₹256.55 crore in the same quarter last year. Total income also showed significant growth, increasing by 23.6% to ₹620.63 crore from ₹502.10 crore in the previous year's corresponding quarter.

Revenue from operations saw a modest increase of 5.8%, reaching ₹338.83 crore compared to ₹320.28 crore in the previous year quarter. The company's basic earnings per share (EPS) improved to ₹3.01 from ₹1.74, reflecting the strong bottom-line growth.

New Leadership Appointment

In a significant management change, Softsol India's board has appointed Dr. Aravind Kumar Madala as an Additional Director and Managing Director of the company. The appointment is effective from September 1, for a five-year term until August 31, 2030, subject to shareholder approval.

Dr. Madala brings a unique background to his new role:

He is a general physician with 19 years of experience in comprehensive medical care.
He completed his graduation and post-graduation from Kasturba Medical College, Mangalore (1996-2006).
Dr. Madala is the son of Mr. Bhaskar Rao Madala, the current Whole Time Director of Softsol India.

Business Segment Focus

Following the demerger of its IT/ITES business to subsidiary Covance Softsol Limited in September 2024, Softsol India now operates solely in the INFRA Business segment. This strategic move has allowed the company to focus on its infrastructure-related operations, potentially contributing to its improved financial performance.

Conclusion

Softsol India's strong quarterly results, coupled with the appointment of Dr. Aravind Kumar Madala as the new Managing Director, indicate a period of positive change for the company. The significant profit growth and the strategic focus on the INFRA Business segment suggest that Softsol India is well-positioned for continued success in the coming quarters.